Kang Stem Biotech is Other Pharmaceuticals and Biotechnology in China that focus on Biotech Co Ltd business. Founded in 2010. They cover business area such as Kangstem Biotech Co Ltd, technology, conversion, purity, large quantity, its Furestem therapy, Furestem-AD, Furestem-RA, Furestem-CD, its business, cord blood-derive stem cell therapy business, medium business.
Other Pharmaceuticals and Biotechnology
2010
( 14 years old in 2024 )
Biotech Co Ltd
-
Teheran Model 512 17-storey buildings Bldg 17th Floor, Sinan., 512
Teheran-ro
Seoul, Gangnam-gu
China
Private
Kangstem Biotech Co Ltdtechnologyconversionpuritylarge quantityits Furestem therapyFurestem-ADFurestem-RAFurestem-CDits businesscord blood-derive stem cell therapy businessmedium business
* We use standard office opening hours in near Kang Stem Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kang Stem Biotech is Other Pharmaceuticals and Biotechnology business from China that founded in 2010 (14 years old in 2024), Kang Stem Biotech business is focusing on Biotech Co Ltd.
Kang Stem Biotech headquarter office and corporate office address is located in Teheran Model 512 17-storey buildings Bldg 17th Floor, Sinan., 512 Teheran-ro Seoul, Gangnam-gu China.
Kang Stem Biotech was founded in China.
In 2024, Kang Stem Biotech is currently focus on Biotech Co Ltd sector.
Above is snippet of Google Trends for "Biotech Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kang Stem Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
